Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer

La biopsia líquida predice la respuesta en pacientes con cáncer de pulmón avanzado

Los investigadores de Johns Hopkins son pioneros en el uso de una “biopsia líquida” para predecir qué pacientes con cánceres de pulmón avanzados están respondiendo a las inmunoterapias y qué pacientes pueden desarrollar efectos secundarios relacionados con el sistema inmunológico varios meses después.

LEER AQUÍ

VER TODAS LAS NOTICIAS

Mensajes recientes

New Technology: MRI-guided Focused Ultrasound for Prostate Cancer Advances in Breast Cancer Treatment: Insights from Medical Oncologist Jenni Sheng Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment